These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 15634714)

  • 1. Complementary secretagogue pairs unmask prominent gender-related contrasts in mechanisms of growth hormone pulse renewal in young adults.
    Soares-Welch C; Farhy L; Mielke KL; Mahmud FH; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Apr; 90(4):2225-32. PubMed ID: 15634714
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of estradiol supplementation on dual peptidyl drive of GH secretion in postmenopausal women.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2002 Feb; 87(2):859-66. PubMed ID: 11836333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential pulsatile secretagogue control of GH secretion in healthy men.
    Norman C; Miles J; Bowers CY; Veldhuis JD
    Am J Physiol Regul Integr Comp Physiol; 2013 May; 304(9):R712-9. PubMed ID: 23485864
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Testosterone supplementation in healthy older men drives GH and IGF-I secretion without potentiating peptidyl secretagogue efficacy.
    Veldhuis JD; Keenan DM; Mielke K; Miles JM; Bowers CY
    Eur J Endocrinol; 2005 Oct; 153(4):577-86. PubMed ID: 16189179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Contributions of gender and systemic estradiol and testosterone concentrations to maximal secretagogue drive of burst-like growth hormone secretion in healthy middle-aged and older adults.
    Veldhuis JD; Patrie JT; Brill KT; Weltman JY; Mueller EE; Bowers CY; Weltman A
    J Clin Endocrinol Metab; 2004 Dec; 89(12):6291-6. PubMed ID: 15579792
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of dual secretagogue drive of burst-like growth hormone secretion in premenopausal women studied under a selective estradiol clamp.
    Erickson D; Keenan DM; Farhy L; Mielke K; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2005 Mar; 90(3):1741-51. PubMed ID: 15613434
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sustained elevation of pulsatile growth hormone (GH) secretion and insulin-like growth factor I (IGF-I), IGF-binding protein-3 (IGFBP-3), and IGFBP-5 concentrations during 30-day continuous subcutaneous infusion of GH-releasing peptide-2 in older men and women.
    Bowers CY; Granda R; Mohan S; Kuipers J; Baylink D; Veldhuis JD
    J Clin Endocrinol Metab; 2004 May; 89(5):2290-300. PubMed ID: 15126555
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preservation of GHRH and GH-releasing peptide-2 efficacy in young men with experimentally induced hypogonadism.
    Veldhuis JD; Keenan DM; Bailey JN; Miles JM; Bowers CY
    Eur J Endocrinol; 2009 Aug; 161(2):293-300. PubMed ID: 19458139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tripartite control of growth hormone secretion in women during controlled estradiol repletion.
    Veldhuis JD; Cosma M; Erickson D; Paulo R; Mielke K; Farhy LS; Bowers CY
    J Clin Endocrinol Metab; 2007 Jun; 92(6):2336-45. PubMed ID: 17405836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion.
    Van den Berghe G; de Zegher F; Veldhuis JD; Wouters P; Awouters M; Verbruggen W; Schetz M; Verwaest C; Lauwers P; Bouillon R; Bowers CY
    J Clin Endocrinol Metab; 1997 Feb; 82(2):590-9. PubMed ID: 9024260
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Continuous 24-hour intravenous infusion of recombinant human growth hormone (GH)-releasing hormone-(1-44)-amide augments pulsatile, entropic, and daily rhythmic GH secretion in postmenopausal women equally in the estrogen-withdrawn and estrogen-supplemented states.
    Evans WS; Anderson SM; Hull LT; Azimi PP; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Feb; 86(2):700-12. PubMed ID: 11158034
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol regulates GH-releasing peptide's interactions with GH-releasing hormone and somatostatin in postmenopausal women.
    Norman C; Rollene NL; Erickson D; Miles JM; Bowers CY; Veldhuis JD
    Eur J Endocrinol; 2014 Jan; 170(1):121-9. PubMed ID: 24114435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E2 supplementation selectively relieves GH's autonegative feedback on GH-releasing peptide-2-stimulated GH secretion.
    Anderson SM; Wideman L; Patrie JT; Weltman A; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2001 Dec; 86(12):5904-11. PubMed ID: 11739462
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dual secretagogue drive of burst-like growth hormone secretion in postmenopausal compared with premenopausal women studied under an experimental estradiol clamp.
    Erickson D; Keenan DM; Mielke K; Bradford K; Bowers CY; Miles JM; Veldhuis JD
    J Clin Endocrinol Metab; 2004 Sep; 89(9):4746-54. PubMed ID: 15356089
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A paradoxical gender dissociation within the growth hormone/insulin-like growth factor I axis during protracted critical illness.
    Van den Berghe G; Baxter RC; Weekers F; Wouters P; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Jan; 85(1):183-92. PubMed ID: 10634385
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oral estradiol administration modulates continuous intravenous growth hormone (GH)-releasing peptide-2-driven GH secretion in postmenopausal women.
    Shah N; Evans WS; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2000 Aug; 85(8):2649-59. PubMed ID: 10946861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History to the discovery of ghrelin.
    Bowers CY
    Methods Enzymol; 2012; 514():3-32. PubMed ID: 22975043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol supplementation enhances submaximal feed-forward drive of growth hormone (GH) secretion by recombinant human GH-releasing hormone-1,44-amide in a putatively somatostatin-withdrawn milieu.
    Veldhuis JD; Evans WS; Bowers CY
    J Clin Endocrinol Metab; 2003 Nov; 88(11):5484-9. PubMed ID: 14602794
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Factors other than sex steroids modulate GHRH and GHRP-2 efficacies in men: evaluation using a GnRH agonist/testosterone clamp.
    Veldhuis JD; Bowers CY
    J Clin Endocrinol Metab; 2009 Jul; 94(7):2544-50. PubMed ID: 19351731
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gonadal status and body mass index jointly determine growth hormone (GH)-releasing hormone/GH-releasing peptide synergy in healthy men.
    Paulo RC; Cosma M; Soares-Welch C; Bailey JN; Mielke KL; Miles JM; Bowers CY; Veldhuis JD
    J Clin Endocrinol Metab; 2008 Mar; 93(3):944-50. PubMed ID: 18073313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.